Exchange: NASDAQ·Updated 07:30 PM EDT
IMMP logo

IMMP Immutep LTD ADR

$0.3649
$0.0002
(0.06%)
Today
Closed $0.3649
$0.0046
(1.26%)
After Hours
EarningsFeb 23
Mkt Cap$53.78M
Vol62,554.00

About IMMP

Immutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune diseases. Its products include eftilagimod alfa (IMP321), IMP761, leramilimab (IMP701), and GSK‘781 (IMP731). The company was founded on May 21, 1987 and is headquartered in Sydney, Australia.
43

Bearish Sentiment

How do you feel about IMMP?

Advertisement|Remove ads.